Myc is essential for transformation by TEL/platelet-derived growth factor receptor β (PDGFRβ)

Blood

Volumn 91, Issue 9, 1998, Pages 3333-3339

  Bourgeade, Marie Françoise ^b   Défachelles, Anne Sophie ^b   Cayre, Yvon E ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR B;

ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION; COLONY FORMATION; DIMERIZATION; DNA BINDING; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSACTIVATION;

EID: 0032079719     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3333.3333_3333_3339     Document Type: Article

References (22)

1. Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5:12) chromosomal translocation. Cell 77:307, 1994
2. Seth A, Papas TS: The c-ets 1 proto-oncogene has oncogenic activity and is positively regulated. Oncogene 5:1761, 1990
3. Rao VN, Ohno T, Prasad DDK, Bhattachayra G, Reddy SP: Analysis of the DNA-binding and transcriptional activated functions of human Fli-1 protein. Oncogene 8:2167, 1993
4. Siddique HR, Rao VN, Lee L, Reedy ES: Characterization of the DNA binding and transactivation domains of the erg protein. Oncogene 8:1751,1993
5. Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG: The TEL/platelet-derived growth factor β (PDGFBR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFR 8β kinase-dependent signalling pathways. Proc Natl Acad Sci USA 93:14845, 1996
6. Jousset C, Carron C, Bourex A, Tran Quang C, Oury C, Dusanter-Fourt I, Charon M, Levin J, Bernard O, Ghysdael J: A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR β oncoprotein. EMBOJ 16:69, 1997
7. Heldin CH: Dimerization of cell surface receptors in signal transduction. Cell 80:213, 1995
8. Pawson T: Protein modules and signalling networks. Nature 373:573, 1995
9. Ullrich A, Schiessinger J: Signal transduction by the receptors with tyrosine kinase activity. Cell 61:203, 1991
10. Satoh T, Fantl WJ, Escobedo JA, Williams LT, Kaziro Y: Platelet-derived growth factor mediates activation of Ras through different signalling pathways in different cell lines. Mol Cell Biol 13:3706, 1993
11. Barone MV, Courtneidge SA: Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature 378:509, 1995
12. Eisenman RN, Cooper AJ: Beating a path to Myc. Nature 378:438, 1995
13. Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H: Oncogenic activity of the c-myc protein requires dimerization with max. Cell 72:233, 1993
14. Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Regenass U, Lydon NB: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Proc Natl Acad Sci USA 92:2558, 1995
15. Golub TR, Goga A, Barker GF, Afar DEH, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG: Oligomerization of the Abl tyrosine kinase by the Ets protein Tel in human leukemia. Mol Cell Biol 16:4107, 1996
16. Sato N, Sakamaki K, Terada N, Arai KI, Miyajima A: Signal transduction by the high affinity GM-CSF receptor: Two distinct cytoplasmic regions of the common beta subunit responsible for different signalling. EMBO J 12:4181, 1993
17. Shibuya H, Yoneyama M, Nonomiya-Tsuji J, Matsumoto K, Taniguchi T: IL2 and EGF receptors stimulate the hematopoietic cell cycle via different signalling pathways: Demonstration of a novel role for c-myc. Cell 70:57, 1992
18. Mukherjee B, Morgenbesser SD, DePinho RA: Myc family oncoproteins function through a common pathway to transform normal cells in culture: Cross interference by Max and transacting dominant mutants. Genes Dev 6:1480, 1992
19. Van XQ, Brady G, Iscove N: Overexpression of PDGF B in murine hematopoietic cells induces a lethal myeloproliferative syndrome in vivo. Oncogene 9:163, 1994
20. Van XQ, Brady G, Iscove NJ: Platelet-derived growth factor (PDGF) activates primitive hematopoietic precursors (preCFC multi) by regulating ILIβ in PDGF receptor expressing macrophages. Immunology 150:2440, 1993
21. Sawyers CL, Callahan W, Witte ON: Dominant negative MYC blocks transformation by Abl oncogenes. Cell 70:901, 1992
22. Lugo TG, Witte ON: The BCR/ABL oncogene transforms Rat-1 cells and cooperates with v-myc. Mol Cell Biol 9:1263, 1989